Skip to main content

Table 3 Infectious complications in common variable immunodeficiency

From: Common variable immunodeficiency - an update

  Mount Sinai 1999 [3] (n = 248) Mount Sinai 2011 [38] (n = 473) DEFI 2008 [4] (n = 252)
Recurrent (respiratory tract) infections 98% (243/248) 94% (445/473) 91% (230/252)
Pneumoniaa 76.6% (190/248) 40% (187/473) 58% (147/252)
Meningitis <1% (2/248) NS 7.9% (20/252)
Viral hepatitis 6.5% (16/248) 3.4% (16/473) 1.2% (3/252)
Giardia enteritis 3.2% (8/248) 2.3% (11/473) 13.9% (35/252)
(Recurrent) Herpes zoster 3.6% (9/248) 2.5% (12/473) 11% (27/252)
Pneumocystis jiroveci infection 2.8% (7/248) 1.3% (6/473) <1% (2/252)
Salmonella infection 1.2% (3/248) <1% (4/473) 7.5% (19/252)
Mycoplasma infection 2.8% (7/248) <1% (4/473) NS
Candidiasis 1.2% (3/248) <1% (3/473) <1% (2/252)
Mycobacterial disease <1% (1/248) <1% (3/473) <1% (2/252)
Papilloma viral infection NS <1% (3/473) <1% (13/252)
  1. aPredominantly bacterial, lobar or bronchopneumonia, X-ray proven. NS, not specified.